Conduit Pharmaceuticals Q1 EPS $(5.56) Up From $(3.67 thousand) YoY

Conduit Pharmaceuticals (NASDAQ:CDT) reported quarterly losses of $(5.56) per share. This is a 99.85 percent increase over losses of $(3.67 thousand) per share from the same period last year.